Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered Intramuscularly Via Electroporation Followed by VSV-gag HIV Vaccine Boost in Healthy, HIV-Uninfected Adults
Clinical trial NCT01578889 · COMPLETED
Trial details
- NCT number
- NCT01578889
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2014-09-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.